FIRST TR EXCHANGE-TRADED FD - NASDQ PHRMTCLS (FTXH)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / NASDQ PHRMTCLS
Number of holders
25
Total shares
493K
Shares change
-199K
Total reported value, excl. options
$12.9M
Value change
-$5.2M
Number of buys
9
Number of sells
-18
Price
$26.19

Significant Holders of FIRST TR EXCHANGE-TRADED FD - NASDQ PHRMTCLS (FTXH) as of Q2 2023

24 filings reported holding FTXH - FIRST TR EXCHANGE-TRADED FD - NASDQ PHRMTCLS as of Q2 2023.
FIRST TR EXCHANGE-TRADED FD - NASDQ PHRMTCLS (FTXH) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 493K shares .
Largest 10 shareholders include Raymond James Financial Services Advisors, Inc. (123K shares), LPL Financial LLC (70.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (41.1K shares), WMG Financial Advisors, LLC (39.2K shares), Kesler, Norman & Wride, LLC (27.5K shares), Paragon Private Wealth Management, LLC (26.2K shares), CITADEL ADVISORS LLC (23K shares), OLD MISSION CAPITAL LLC (21.7K shares), Cambridge Investment Research Advisors, Inc. (15.6K shares), and Steward Partners Investment Advisory, LLC (15.1K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.